Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation

Revista Brasileira de Hematologia e Hemoterapia

Navneet Singh Majhail²  James Douglas Rizzo¹  Stephanie Joi Lee¹  Mahmoud Aljurf¹  Yoshiko Atsuta¹  Carmem Bonfim¹  Linda Jean Burns¹  Naeem Chaudhri¹  Stella Davies¹  Shinichiro Okamoto¹  Adriana Seber¹  Gerard Socie¹  Jeff Szer¹  Maria Teresa Van Lint¹  John Reid Wingard¹  Andre Tichelli¹ 

[1] ,National Marrow Donor ProgramMinneapolis MN ,USA

关键词: hematopoietic cell transplantation;    allogeneic;    autologous;    late complications;    screening;    prevention;    transplante de células-tronco hematopoéticas;    alogênico;    autólogo;    complicações tardias;    triagem;    prevenção;   

DOI  :  10.5581/1516-8484.20120032

来源: SciELO

【 摘 要 】

Advances in hematopoietic cell transplantation (HCT) technology and supportive care techniques have led to improvements in long-term survival after HCT. Emerging indications for transplantation, introduction of newer graft sources (e.g. umbilical cord blood) and transplantation of older patients using less intense conditioning regimens have also contributed to an increase in the number of HCT survivors. These survivors are at risk for developing late complications secondary to pre-, periand post-transplant exposures and risk-factors. Guidelines for screening and preventive practices for HCT survivors were published in 2006. An international group of transplant experts was convened in 2011 to review contemporary literature and update the recommendations while considering the changing practice of transplantation and international applicability of these guidelines. This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT.

【 授权许可】

CC BY-NC-ND   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License